Ads
related to: actemra indications for medication administration and billing system for patients- Patient Support Services
Visit The Site To Learn About
Patient Access Services.
- Efficacy & Safety
Learn About The Efficacy & Safety
Before Prescribing To Your Patients
- Clinical Information
View Efficacy & Safety Info Across
Multiple Clinical Studies
- Contact A Representative
Contact A Representative To
Get More Info About ACTEMRA®.
- Important Safety Info
Read The Full Safety Profile
Including Boxed Warning.
- Resource Library
View Additional HCP Resources
To Learn About Treatment.
- Patient Support Services
Search results
Results From The WOW.Com Content Network
Tocilizumab, sold under the brand name Actemra among others, is an immunosuppressive drug, used for the treatment of rheumatoid arthritis, systemic juvenile idiopathic arthritis, polyarticular juvenile idiopathic arthritis, giant cell arteritis, cytokine release syndrome, COVID‑19, and systemic sclerosis-associated interstitial lung disease (SSc-ILD).
The first approved medication in this class, tocilizumab (Actemra), is an antibody directed against the IL6-receptor. [8] The second, siltuximab (Sylvant), is directed against IL-6 itself. [1] [9] Siltuximab is approved for treatment of human immunodeficiency virus-negative and HHV-8-negative patients with multicentric Castleman's disease.
An antiarthritic is any drug used to relieve or prevent arthritic symptoms, such as joint pain or joint stiffness. Depending on the antiarthritic drug class, it is used for managing pain, reducing inflammation or acting as an immunosuppressant. These drugs are typically given orally, topically or through administration by injection.
Roche (RHHBY) commences a phase III study on Actemra with Gilead's remdesivir in hospitalized patients with severe COVID-19 pneumonia.
For premium support please call: 800-290-4726 more ways to reach us
In the United States, the Food and Drug Administration (FDA) determines the requirements for patient package inserts. In the United States, the FDA will occasionally issue revisions to previously approved package inserts, in much the same way as an auto manufacturer will issue recalls upon discovering a problem with a certain car.
Ads
related to: actemra indications for medication administration and billing system for patientsquotes.expertmarket.com has been visited by 100K+ users in the past month